NCT03939429View on ClinicalTrials.gov

Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 20, 2019

Primary Completion Date

October 6, 2019

Study Completion Date

October 6, 2019

Conditions
Bacterial Infections
Interventions
DRUG

QPX2015

antibiotic

DRUG

Placebo oral capsule

Placebo comparator

Trial Locations (1)

Unknown

CMAX, Adelaide

All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Qpex Biopharma, Inc.

INDUSTRY

NCT03939429 - Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter